Name: Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America
Price: 109.67 USD
Availability: InStock
Author: Jennifer R., MD, PhD Brown?;Matthew S., MD, MMSc Davids
ISBN: 9780443345470

portada Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

Formato

Libro Físico

Editorial

Churchill Livingstone

Autor

Jennifer R., MD, PhD Brown?;Matthew S., MD, MMSc Davids

Colección

The Clinics: Internal Medicine

Año

2025

N° páginas

240

Encuadernación

Tapa Dura

Dimensiones

22.90 x 15.20 cm

ISBN13

9780443345470

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

Jennifer R., Md, Phd Brown?;Matthew S., Md, Mmsc Davids (Autor) · Churchill Livingstone · Tapa Dura

Libro Nuevo Importado

Envío: 19 a 24 días háb.

$ 219.33$ 109.67

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 109.67

Llega entre el 21 Ago y el 01 Sep a FL. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America"

In this issue of Hematology/Oncology Clinics, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of Chronic Lymphocytic Leukemia. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction-offering a state-of-the-art overview of the field to help optimize the care of patients with CLL. Contains 13 relevant, practice-oriented topics including autonomous B cell receptor signaling; triple drug combinations; management of relapsed/refractory CLL; resistance to BTK inhibitors; immune therapy for CLL; and moreProvides in-depth clinical reviews on chronic lymphocytic leukemia, offering actionable insights for clinical practicePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews